Roivant Reports Financial Results for the Third Quarter Ende

BASEL, Switzerland and LONDON and NEW YORK, Feb. 13, 2024 -- Roivant today reported its financial results for the third quarter ended December 31, 2023, and provided a business update. Roivant...

Related Keywords

Japan , London , City Of , United Kingdom , Switzerland , Matt Gline , Stephanie Lee , Exchange Commission , Securities Exchange , Pfizer , National Prescription Audit , Proteovant Sciences Inc , Roivant Sciences Ltd , Roivant Sciences , Development Expenses , Eczema Area , Severity Index , Peak Pruritus Numeric Rating Scale , Quarter Ended December , Proteovant Sciences , Telavant Net , Consolidated Statements , Securities Act , Securities Exchange Act , Risk Factors , Prescription Audit , Markets ,